Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Adicionar filtros








Intervalo de ano
1.
Yonsei Medical Journal ; : 159-162, 2008.
Artigo em Inglês | WPRIM | ID: wpr-158186

RESUMO

The concurrence of ankylosing spondylitis (AS) in a patient with mixed connective tissue disease (MCTD) is rarely described in the literature. Significant and sustained efficacy with tumor necrosis factor (TNF)-alpha blockers has been demonstrated in AS patients. However, evidence to date has revealed associated side effects, including antinuclear antibody induction and development of a lupus-like syndrome. Several authors have reported lupus-like manifestations in MCTD patients treated with TNF-alpha blockers used to control peripheral polyarthritis. In our case report, we demonstrate a good response to etanercept therapy for refractory sacroiliitis in a patient with coexisting AS and MCTD, without development of a lupus-like syndrome. This demonstrates that etanercept therapy may be an appropriate therapeutic agent for sacroiliitis in MCTD patients, as it is in AS alone.


Assuntos
Feminino , Humanos , Pessoa de Meia-Idade , Imunoglobulina G/uso terapêutico , Imageamento por Ressonância Magnética , Doença Mista do Tecido Conjuntivo/complicações , Receptores do Fator de Necrose Tumoral/uso terapêutico , Articulação Sacroilíaca/efeitos dos fármacos , Espondilite Anquilosante/complicações , Resultado do Tratamento
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA